Form 4: Avadel Pharmaceuticals Director Linda Palczuk Reports Stock Transaction
SEC Form 4 Filing
Director Linda Palczuk reported a disposition of 3,500 ordinary shares of Avadel Pharmaceuticals on December 24, 2024.
Summary
- On December 24, 2024, Linda Palczuk, a director of Avadel Pharmaceuticals PLC, disposed of 3,500 ordinary shares.
- The transaction was a disposition, indicated by code 'G', and the price was $0.00.
- Following the transaction, Palczuk beneficially owns 62,900 ordinary shares directly.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These filings are monitored by investors to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as insider transactions are often scrutinized for insights into the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 12/24/2024 | Date of transaction: Linda Palczuk disposed of 3,500 ordinary shares. |
| 12/27/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.